Advances in Trace Element Supplementation for Parenteral Nutrition

Area of Science:

• Parenteral nutrition
• Trace element supplementation
• Drug regulation

Background:

• Parenteral nutrition (PN) is vital for patients with intestinal absorption issues.
• Historically, trace element (TE) supplementation in PN lacked rigorous oversight.
• Evolving guidelines from the American Society for Parenteral and Enteral Nutrition (ASPEN) and FDA have driven improvements.

Purpose of the Study:

• To examine the rationale behind the development of TRALEMENT® (Trace Elements Injection 4*).
• To detail the FDA's stringent requirements for reviewing and approving new multi-TE products.
• To highlight the collaborative effort involving the FDA, industry, and clinical experts.

Main Methods:

• Review of the development process for TRALEMENT®.
• Analysis of FDA regulatory requirements for multi-TE products.
• Examination of ASPEN's updated dosage recommendations for PN.

Main Results:

• TRALEMENT® is a new multi-TE product containing copper, manganese, selenium, and zinc.
• The product meets ASPEN recommendations and FDA requirements.
• It is approved for adults and pediatric patients weighing ≥10 kg.

Conclusions:

• The development of TRALEMENT® signifies progress in ensuring safer and more effective TE supplementation in PN.
• Comprehensive PN management requires careful consideration of TE requirements.
• Collaboration is key to advancing PN therapy and patient care.